# Boston Analytical, Inc. – FDA Inspection, Jan 24, 2020

Source: https://www.keypedia.com/records/fda_inspections/boston-analytical-inc/27999c69-291d-43e4-8c15-172499a9e849
Source feed: FDA_Inspections

> FDA inspection 1115784 of Boston Analytical, Inc., January 24, 2020. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1115784
- Company Name: Boston Analytical, Inc.
- Inspection Date: 2020-01-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1200703 - 2023-03-07
- [FDA Inspection 1076790 - 2019-01-15](https://www.keypedia.com/records/fda_inspections/boston-analytical-inc/87750cf2-8a29-4c50-bbbc-b9b7862bfc85)
- FDA Inspection 987020 - 2016-09-22
- [FDA Inspection 941530 - 2015-06-23](https://www.keypedia.com/records/fda_inspections/boston-analytical-inc/5563b7ed-aa98-4b99-8aed-0cd2f603289a)
- FDA Inspection 814115 - 2012-11-09

Company: https://www.keypedia.com/companies/boston-analytical-inc/a21fce05-8b60-4a91-ac00-217015ac046a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c